Tuesday, 29 September 2026Updated 39m ago
← Top stories
Deal● Neutral for Indian equities

AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs

1 source · first seen 03:57 29 Sept · updated 03:57 29 Sept

The brief

Written from 1 report · check the source before you trade
  • AstraZeneca plans to invest $2 billion in Summit Therapeutics
  • The companies plan to ramp up their collaboration on cancer drugs

Tags on this story

Pick a tag to see all its stories
Pharma and healthcare35 today

Linked by the tag Pharma and healthcare

86 stories this week
  1. 28 SeptUS exempts India and 19 nations from 100% tariff on certain speciality drugs: ReportPolicy · 1 source · US exempts certain speciality drugs and ingredients imported from India from tariffs
  2. 27 SeptFortis says independent audit will establish non-involvement in Singh brothers’ share transfersLegal · 2 sources · Supreme Court cleared the way for an independent forensic audit of the share transfers
  3. 27 SeptFortis confident of clean chit from audit in Singh brothers’ disputeLegal · 1 source · Fortis expects a clean chit from the audit in the Singh brothers’ dispute
  4. 25 SeptSupreme Court allows independent forensic audit of Fortis transactions in Daiichi disputeLegal · 7 sources · The Supreme Court declined to interfere with Delhi High Court orders allowing the audit
  5. 25 SeptRegulator mulls digital platform for drugmakers' test reportsPolicy · 1 source · India’s drug regulator is developing a digital platform for consumers to view batch-level quality-test reports
All Pharma and healthcare stories →

Read the reports

1 report · earliest 03:57
WSJAstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs03:57